Asia Pacific Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)

Name: Asia Pacific Embolization Agents Market
SKU: Medical Device
Rating: 4.9 (15 reviews)

Market Introduction

The APAC embolization agents market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of APAC. The growth of the market in the APAC region is expected to grow at a faster pace owing to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period. As per the World Herat Federation, non-communicable diseases, including CVDs, are estimated to account for 87% of total adult deaths in China. China has one of the highest CVD death rates in the world. The burden of cardiovascular diseases is spurred significantly due to high blood pressure; other factors such as the high prevalence of smoking, unhealthy diet has also contributed to the rising incidences of cardiovascular diseases. There are more than 300 million smokers in the country. As the population ages at an ever-faster pace, it is expected that the number of patients with chronic diseases will increase. The incidences of stroke have increased in the past years, and the incidences of abdominal aortic aneurysm have increased in the country, driving the adoption of embolization agents in the forecast period. Given that, the government of China has invested more in the prevention and treatment of non-communicable diseases. Also, the advanced techniques for stroke prevention and treatment procedures have facilitated the standardization of stroke care for physicians and improved their skills across the country. In addition, the robust healthcare infrastructure in the country is facilitating the adoption of advanced technologies. For instance, nearly 7.4% of the 124 hospitals have established stroke units in Beijing. Also, approximately 300 stroke units have been established across the country, driving the market's growth. Moreover, in China, to meet the population's healthcare needs, the country has developed Healthy China 2030. Also, market players are engaged in strategic activities to expand their footprint in the market. For instance, in May 2021, Grand Pharmaceutical and Healthcare Holdings Limited acquired rights to Shenming Medical Technology Co., Ltd.'s innovative thermosensitive embolic agent to treat liver cancer, further expanding the tumor intervention treatment product pipeline. Therefore, owing to the factors mentioned above, the market for the embolization agents to grow significantly in the forecast period

The COVID-19 pandemic has led to a decline in cardiac procedures in Asia Pacific countries. For instance, the number of cardiac surgeries performed between April and July at the All-India Institute of Medical Sciences (AIIMS) dropped by 89.5%. Similarly, Australia has also recorded a reduction in cardiac surgeries. The study reported in Heart, Lung & Circulation showed that from March to June 2020, 136 adults underwent cardiac surgery, representing a 21% drop in operative caseload in Australia. The Further, outbreak has severely affected the medical tourism industry in Asia Pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to underdeveloped healthcare infrastructures in developing countries, restrictions imposed on suppliers by hospitals, decreasing in demand for cardiovascular surgical instruments, etc. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission, which are impacting supply chains and medical device availability in these countries. They have also affected disposable incomes and resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. However, surge in the pace of vaccination drives and availability of government reimbursement policies for various cardiovascular procedures are expected to normalize the situation in Asia Pacific and will gradually boost the demand for embolization products in the coming years.

Get more information on this report :

Market Overview and Dynamics

The embolization agents market in Asia Pacific is expected to grow from US$ 585.86 million in 2021 to US$ 1,022.36 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. Surge in Incidence of hypertension, obesity, smoking, and alcoholism; hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for embolization agents market. Kidney cancer is becoming more common in people of all ages, races, and tumor sizes. Hypertension, being overweight, and smoking are all risk factors for kidney cancer. Obesity is associated with high blood pressure, dyslipidemia, diabetes, or insulin resistance, as well as higher fibrinogen and C-reactive protein levels, all of which increase the risk of cardiovascular diseases (CVD) events. Obesity has been associated with a higher risk of high blood pressure, in addition to CVD. Embolizing agents like the Amplatzer Vascular Plug (AVP) was created for peripheral embolization as a modification of the family of Amplatz septal occluders used in the treatment of congenital heart malformations. Thus, increasing prevalence of hypertension, smoking, alcoholism, and obesity requiring mobility assistance is likely to favor the growth of the APAC embolization agents market.

Key Market Segments

Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, others. The beads/particles segment held the largest share of the market in 2020. Based on coils the market is divided into detachable coils and pushable coils. The pushable coils segment held the largest share of the market in 2020. Based on beads/particles the market is divided into spherical and non-spherical. The pushable non-spherical segment held the largest share of the market in 2020. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2020, the oncology segment is likely to hold the largest share of the market. The embolization agents market by end user, is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held the largest share of the market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the embolization agents market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Boston Scientific Corporation; Cook Medical LLC; DePuy Synthes; KANEKA CORPORATION; Medtronic; Merit Medical Systems Inc; Penumbra, Inc.; Stryker Corporation; and Terumo Corporation among others.

Reasons to buy report

To understand the Asia Pacific embolization agents market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific embolization agents market
Efficiently plan M&A and partnership deals in Asia Pacific embolization agents market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific embolization agents market
Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

ASIA PACIFIC EMBOLIZATION AGENTS MARKET SEGMENTATION

By Product

Coils
- Detachable Coils
- Pushable Coils
Beads/ Particles
- Spherical
- Non-Spherical
Plugs
Detachable Balloons
Glue
Sponge
Liquid Embolics
Sclerosants
Precipitating Agents
Others

By Application

By End User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

By Country

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Embolization Agents Market – By Product

1.3.2 APAC Embolization Agents Market – By Application

1.3.3 APAC Embolization Agents Market – By End User

1.3.4 APAC Embolization Agents Market – By Country

2. APAC Embolization Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Embolization Agents Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 APAC – PEST Analysis

4.3 Experts Opinion

5. APAC Embolization Agents Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Tumors and Aneurysms

5.1.1 Surge in Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 High Cost of Embolization Agents

5.3 Market Opportunities

5.3.1 Growing Geriatric Population Base

5.4 Future Trends

5.4.1 Technological Advancements in Embolization Products and Procedures

5.5 Impact analysis

6. Embolization Agents Market – APAC Analysis

6.1 APAC Embolization Agents Market Revenue Forecast and Analysis

7. APAC Embolization Agents Market Analysis – By Product

7.1 Overview

7.2 APAC Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3 Coils

7.3.1 Overview

7.3.2 Coils: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Detachable Coils

7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2 Pushable Coils

7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Beads/Particles

7.4.1 Overview

7.4.2 Beads/Particles: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Spherical

7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2 Non-Spherical

7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Plugs

7.5.1 Overview

7.5.2 Plugs: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Detachable Balloons

7.6.1 Overview

7.6.2 Detachable Balloons: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7 Glue

7.7.1 Overview

7.7.2 Glue: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8 Sponge

7.8.1 Overview

7.8.2 Sponge: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9 Liquid Embolics

7.9.1 Overview

7.9.2 Liquid Embolics: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10 Sclerosants

7.10.1 Overview

7.10.2 Sclerosants: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11 Precipitating Agents

7.11.1 Overview

7.11.2 Precipitating Agents: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12 Others

7.12.1 Overview

7.12.2 Others: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8. APAC Embolization Agents Market Analysis – By Application

8.1 Overview

8.2 APAC Embolization Agents Market, by Application 2021 & 2028 (%)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Urology

8.5.1 Overview

8.5.2 Urology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Cardiology

8.6.1 Overview

8.6.2 Cardiology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Peripheral Vascular Diseases

8.7.1 Overview

8.7.2 Peripheral Vascular Diseases: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Embolization Agents Market Analysis – By End User

9.1 Overview

9.2 APAC Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Cardiac Centers

9.4.1 Overview

9.4.2 Cardiac Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Embolization Agents Market – Country Analysis

10.1 APAC: Embolization Agents Market

10.1.1 Overview

10.1.2 APAC: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Embolization Agents Market, By Coil, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)

10.1.2.1.3 China: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Embolization Agents Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Embolization Agents Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Embolization Agents Market, By Coil, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)

10.1.2.3.3 India: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Embolization Agents Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Embolization Agents Market, By Coil, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Embolization Agents Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Embolization Agents Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Embolization Agents Market, by Product, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Embolization Agents Market, By Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Embolization Agents Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on APAC Embolization Agents Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. APAC Embolization Agents Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Medtronic

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Terumo Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boston Scientific Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Stryker Corporation

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Penumbra, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Merit Medical Systems Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DePuy Synthes

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 KANEKA CORPORATION

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2. China: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3. China: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)

Table 4. China: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 5. China: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 13. India: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)

Table 14. India: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18. Australia: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)

Table 19. Australia: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of APAC: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Organic Developments Done by Companies

Table 33. Inorganic Developments Done by Companies

Table 34. Glossary of Terms, APAC Embolization Agents Market

LIST OF FIGURES

Figure 1. APAC Embolization Agents Market Segmentation

Figure 2. APAC Embolization Agents Market Segmentation, By Country

Figure 3. APAC Embolization Agents Market Overview

Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in APAC Embolization Agents Market

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8. APAC Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. APAC Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10. Coils: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11. Beads/Particles: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Plugs: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Detachable Balloons: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Glue: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Sponge: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolics: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Sclerosants: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Precipitating Agents: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21. Oncology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Neurology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Urology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Cardiology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Peripheral Vascular Diseases: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28. Hospitals: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Cardiac Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Ambulatory Surgical Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. APAC: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33. APAC: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34. China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000